drugset / Trial / NCT01716026
Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this protocol is to determine wether the initial protocol in the treatment of subfoveal choroidal neovascularization associated to High Myopia with bevacizumab intravitreal injections is more effective when using 3 doses vs using 1 single dose in the load period
Timeline
- Start
- 2012-10
- Primary completion
- 2018-04
- Completion
- 2018-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | — | Intravitreal |